Search

Your search keyword '"Cernohous P"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Cernohous P" Remove constraint Author: "Cernohous P"
35 results on '"Cernohous P"'

Search Results

1. Disks in Nearby Young Stellar Associations Found Via Virtual Reality

2. Follow-up Imaging of Disk Candidates from the Disk Detective Citizen Science Project: New Discoveries and False-Positives in WISE Circumstellar Disk Surveys

3. Disk Detective: Discovery of New Circumstellar Disk Candidates through Citizen Science

4. A Mandala: A Diagram of the Clinical Education Experience in Athletic Training

15. Role of Architecture on the Conformation, Rheology, and Orientation Behavior of Linear, Star, and Hyperbranched Polymer Melts. 1. Synthesis and Molecular Characterization

16. Unusual contributions of molecular architecture to rheology and flow birefringence in hyperbranched polystyrene melts

18. Reaction Kinetics of End-Functionalized Chains at a Polystyrene/Poly(methyl methacrylate) Interface

19. Interfacial Reaction Induced Roughening in Polymer Blends

20. Anionic Synthesis, Modification, and Characterization of ABC Triblock Copolymers

21. Amine-Terminal Polystyrenes:  A New Strategy for Synthesis and New Methods for Determination of Functionality

22. Anionic Synthesis of Polymers Functionalized with a Terminal Anhydride Group

23. A humanitarian mission in southern Iraq: utilization of the 7th Field Hospital of the Army of the Czech Republic--a report on its medical activities and working conditions.

24. Pacritinib, a Dual JAK2/FLT3 Inhibitor: An Integrated Efficacy and Safety Analysis Of Phase II Trial Data In Patients With Primary and Secondary Myelofibrosis (MF) and Platelet Counts ≤100,000/µl

25. CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study

26. Phase 3 Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin Lymphoma (EXTEND): End of Study Results.

28. Abstracts

29. Phase III Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin's Lymphoma (EXTEND): Results From the Treatment and Follow-up Periods.

30. ChemInform Abstract: An Efficient (One‐Pot) Synthesis of a New Class of Cyclophanes.

31. Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial.

32. Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial

33. Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphoma.

34. Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients.

35. Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine.

Catalog

Books, media, physical & digital resources